This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Momotaro-Gene Inc., Okayama University. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 10 
1 out of 138 
Years Active: 2017
Title: Hideo Ueki: Innovator in Cancer Immunotherapy
Introduction
Hideo Ueki is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of cancer immunotherapy through his innovative research and patents. His work focuses on the development of polypeptides that can enhance the immune response against cancer.
Latest Patents
Ueki holds a patent for a "Partial region polypeptide of REIC/Dkk-3 protein." This polypeptide is capable of strongly inducing and activating dendritic-cell-like cells, which are crucial for treating or preventing cancer through immunotherapy. The patent also includes DNA encoding the polypeptide, which consists of a partial region of the REIC/Dkk-3 protein.
Career Highlights
Throughout his career, Ueki has been associated with reputable institutions such as Okayama University and Momotaro Gene Inc. His work has been instrumental in advancing the understanding of cancer treatment methodologies.
Collaborations
Ueki has collaborated with notable colleagues, including Hiromi Kumon and Masami Watanabe. These partnerships have contributed to the success of his research and the development of innovative therapeutic approaches.
Conclusion
Hideo Ueki's contributions to cancer immunotherapy through his patented innovations highlight his role as a leading inventor in the field. His work continues to inspire advancements in cancer treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile